Aurora Cannabis Stock Pattern Recognition Engulfing Pattern

ACB Stock  USD 3.59  0.05  1.41%   
The pattern recognition module provides an execution environment for Engulfing Pattern recognition and related indicators on Aurora Cannabis. This view tracks pattern recognition signals tied to momentum and continuation to support structured performance interpretation without implying advice.

Recognition
The output start index for this execution was two with a total number of output elements of fifty-nine. The function generated a total of nine valid pattern recognition events for the selected time horizon. The Engulfing Pattern describes Aurora Cannabis bullish reversal pattern.

Aurora Cannabis Technical Analysis Modules

Most technical analysis of Aurora Cannabis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aurora from various momentum indicators to cycle indicators. When you analyze Aurora charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aurora Cannabis Inc

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis is traded on NASDAQ Exchange in the United States. A high-level view of Aurora Cannabis emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 46.94, P/B of 0.51, profit margin of -22.51%. Aurora Cannabis has market cap of 200.75 M, P/E of 46.94, ROE of -15.51%.

Methodology

Unless otherwise specified, financial data for Aurora Cannabis is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Aurora (USA Stocks:ACB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Aurora Cannabis is covered by 5 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, among others. Updates may occur throughout the day.


Learn to be your own money manager

Tracking Aurora Cannabis inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Aurora Cannabis pair trading

Pair trading with Aurora Cannabis can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Aurora Cannabis Pair Trading

Aurora Cannabis Pair Trading Analysis

Correlation analysis helps investors find suitable substitutes for Aurora Cannabis during tax-loss harvesting periods. Selling Aurora Cannabis at a loss and immediately repurchasing it would violate IRS wash-sale rules, so a correlated replacement asset is required to maintain portfolio.
Measuring the statistical correlation of Aurora Cannabis against other instruments helps investors understand portfolio diversification. A correlation near zero implies that Aurora Cannabis provides genuine diversification benefits, while high positive correlations suggest redundant exposures.
Correlation analysis and pair trading evaluation for Aurora Cannabis can be used to frame hedging context. The context can be applied within sectors, industries, or broader universes.
Pair CorrelationCorrelation Matching

More Resources for Aurora Stock Analysis

A structured review of Aurora Cannabis often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Aurora Cannabis Stock in context:
Aurora Cannabis has market cap of 200.75 M, P/E of 46.94, operating margin of 2.32%. Use Trending Equities to explore allocation context. This includes a position in Aurora Cannabis across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
For more information on how to buy Aurora Stock please use our How to Buy Aurora Stock guide.
Analysis related to Aurora Cannabis should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
 Quarterly Earnings Growth
-0.95
 Earnings Share
-1.10
 Revenue Per Share
6.644
 Quarterly Revenue Growth
0.068
 Return On Assets
-0.04
The market value of Aurora Cannabis is measured differently than book value, which reflects Aurora accounting equity. Aurora Cannabis' market capitalization is 200.75 M. A P/B ratio of 0.51 suggests Aurora Cannabis trades near or below book value. Enterprise value stands at 194.2 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Aurora Cannabis' intrinsic value and market price are different measures derived from different inputs. For Aurora Cannabis, key inputs include a P/E ratio of 46.94, a P/B ratio of 0.51, a profit margin of -22.51%, ROE of -15.51%. Trading price represents the transaction level agreed by market participants.